The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.112.11.898

Eight schizophrenic patients received chlorpromazine and group psychotherapy, 8 received only chlorpromazine, and 7 patients acted as control. The two groups receiving the drug improved significantly more than the control in practically all measures. The 8 patients receiving group therapy in addition to the drug showed greater improvement than the drug-only group. Chlorpromazine is an effective adjunct to other therapies when used properly. It is not effective with all types of patients.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.